Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9B137
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.727 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.357 |
CLV_PCSK_FUR_1 | 23 | 27 | PF00082 | 0.309 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.312 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.352 |
CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.375 |
DOC_MAPK_gen_1 | 23 | 33 | PF00069 | 0.525 |
LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.525 |
LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.538 |
LIG_APCC_ABBA_1 | 31 | 36 | PF00400 | 0.526 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.584 |
LIG_BRCT_BRCA1_1 | 72 | 76 | PF00533 | 0.591 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.464 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.679 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.457 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.523 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.724 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.649 |
LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.555 |
LIG_PDZ_Class_2 | 151 | 156 | PF00595 | 0.669 |
LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.512 |
LIG_SH2_STAT3 | 64 | 67 | PF00017 | 0.632 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.519 |
LIG_SUMO_SIM_anti_2 | 149 | 156 | PF11976 | 0.672 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.583 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.670 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.411 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.718 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.754 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.597 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.615 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.583 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.479 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.664 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.578 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.586 |
MOD_Plk_1 | 70 | 76 | PF00069 | 0.543 |
MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.648 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.561 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.655 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.523 |
TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.546 |
TRG_NLS_MonoExtC_3 | 24 | 29 | PF00514 | 0.568 |
TRG_NLS_MonoExtN_4 | 23 | 29 | PF00514 | 0.568 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5G5 | Leptomonas seymouri | 72% | 100% |
A0A3Q8IS54 | Leishmania donovani | 90% | 100% |
A4HIJ8 | Leishmania braziliensis | 76% | 100% |
A4I5U2 | Leishmania infantum | 90% | 100% |
Q4Q729 | Leishmania major | 89% | 100% |
V5DP06 | Trypanosoma cruzi | 50% | 99% |